Home
VKTX
VKTX News

Latest Viking Therapeutics Inc. (VKTX) News on May 10, 2025

Why Viking Therapeutics Stock Surged Nearly 20% Higher in April

Motley Fool

4 days ago

Why Viking Therapeutics Stock Surged Nearly 20% Higher in April

Why Viking Therapeutics Stock Was Victorious This Week

Motley Fool

7 days ago

Why Viking Therapeutics Stock Was Victorious This Week

Viking Therapeutics (NasdaqCM:VKTX) Reports Increased Net Loss of US$46 Million in Q1 2025

Simply Wall St.

7 days ago

Viking Therapeutics (NasdaqCM:VKTX) Reports Increased Net Loss of US$46 Million in Q1 2025

Why Eli Lilly, Viking Therapeutics, and Novo Nordisk Stocks All Popped Friday

Motley Fool

7 days ago

Why Eli Lilly, Viking Therapeutics, and Novo Nordisk Stocks All Popped Friday

Is Novo Nordisk Stock a Buy?

Motley Fool

8 days ago

Is Novo Nordisk Stock a Buy?

Where Will Viking Therapeutics Be in 3 Years?

Motley Fool

8 days ago

Where Will Viking Therapeutics Be in 3 Years?

1 Beaten-Down Stock to Buy and Hold for 10 Years

Motley Fool

9 days ago

1 Beaten-Down Stock to Buy and Hold for 10 Years

Will Pfizer Acquire Altimmune or Viking Therapeutics After Its Obesity Pill Setback?

Motley Fool

10 days ago

Will Pfizer Acquire Altimmune or Viking Therapeutics After Its Obesity Pill Setback?

Prediction: Pfizer's Loss May Be Viking Therapeutics' Gain

Motley Fool

10 days ago

Prediction: Pfizer's Loss May Be Viking Therapeutics' Gain

Why Viking Therapeutics Stock Popped Again Today

Motley Fool

10 days ago

Why Viking Therapeutics Stock Popped Again Today

MT Newswires

11 days ago

Cantor Fitzgerald Initiates Viking Therapeutics at Overweight With $104 Price Target

Why Viking Therapeutics Stock Popped Today

Motley Fool

11 days ago

Why Viking Therapeutics Stock Popped Today

MT Newswires

14 days ago

Truist Securities Cuts Viking Therapeutics Price Target to $75 From $95, Maintains Buy Rating

Viking Therapeutics (NasdaqCM:VKTX) Reports Increased Net Loss for Q1 2025

Simply Wall St.

15 days ago

Viking Therapeutics (NasdaqCM:VKTX) Reports Increased Net Loss for Q1 2025

MT Newswires

15 days ago

B. Riley Adjusts Price Target on Viking Therapeutics to $85 From $96, Maintains Buy Rating

Thomson Reuters StreetEvents

15 days ago

Q1 2025 Viking Therapeutics Inc Earnings Call

Viking Therapeutics Q1 Loss Wider Than Expected, Sales Nil, Stock Dips

Zacks

16 days ago

Viking Therapeutics Q1 Loss Wider Than Expected, Sales Nil, Stock Dips

Viking Therapeutics Inc (VKTX) Q1 2025 Earnings Call Highlights: Strategic Advances Amid Rising ...

GuruFocus.com

16 days ago

Viking Therapeutics Inc (VKTX) Q1 2025 Earnings Call Highlights: Strategic Advances Amid Rising ...

Viking Therapeutics, Inc. (VKTX): Among Takeover Rumors Hedge Funds Are Buying

Insider Monkey

16 days ago

Viking Therapeutics, Inc. (VKTX): Among Takeover Rumors Hedge Funds Are Buying

MT Newswires

16 days ago

Viking Therapeutics Q1 Loss Widens; Shares Drop After Hours

MT Newswires

17 days ago

Oppenheimer Cuts Price Target on Viking Therapeutics to $100 From $164, Keeps Outperform Rating

Is Viking Therapeutics (VKTX) a Buy as Wall Street Analysts Look Optimistic?

Zacks

17 days ago

Is Viking Therapeutics (VKTX) a Buy as Wall Street Analysts Look Optimistic?

LLY Stock Up as Oral GLP-1 Pill Meets Goals in First Phase III Study

Zacks

19 days ago

LLY Stock Up as Oral GLP-1 Pill Meets Goals in First Phase III Study

Viking Therapeutics to Report Q1 Earnings: What's in the Cards?

Zacks

19 days ago

Viking Therapeutics to Report Q1 Earnings: What's in the Cards?

Viking Therapeutics (NasdaqCM:VKTX) Completes Enrollment For Phase 2 Trial Of VK2735

Simply Wall St.

21 days ago

Viking Therapeutics (NasdaqCM:VKTX) Completes Enrollment For Phase 2 Trial Of VK2735

H.C. Wainwright still expects Viking to ‘differentiate’ after Lilly data

TipRanks

21 days ago

H.C. Wainwright still expects Viking to ‘differentiate’ after Lilly data

Eli Lilly jumps as results from weight-loss pill study rival competitor’s

TipRanks

21 days ago

Eli Lilly jumps as results from weight-loss pill study rival competitor’s

JPMorgan says Lilly data ‘highly favorable’ for Structure Therapeutics

TipRanks

21 days ago

JPMorgan says Lilly data ‘highly favorable’ for Structure Therapeutics

Viking Therapeutics, Inc. (VKTX) Beats Stock Market Upswing: What Investors Need to Know

Zacks

22 days ago

Viking Therapeutics, Inc. (VKTX) Beats Stock Market Upswing: What Investors Need to Know

Eli Lilly Rockets 14% After Solidifying Its Lead For A Weight-Loss Pill

Investor's Business Daily

22 days ago

Eli Lilly Rockets 14% After Solidifying Its Lead For A Weight-Loss Pill

Why Eli Lilly Stock Is Soaring Today, While Novo Nordisk and Viking Therapeutics Slide

Motley Fool

22 days ago

Why Eli Lilly Stock Is Soaring Today, While Novo Nordisk and Viking Therapeutics Slide

2 Stocks Down by 25% or More This Year to Buy and Hold

Motley Fool

22 days ago

2 Stocks Down by 25% or More This Year to Buy and Hold

Eli Lilly Rockets 12% After Solidifying Its Lead For A Weight-Loss Pill

Investor's Business Daily

23 days ago

Eli Lilly Rockets 12% After Solidifying Its Lead For A Weight-Loss Pill

Viking Therapeutics to Report Financial Results for First Quarter 2025 on April 23, 2025

PR Newswire

23 days ago

Viking Therapeutics to Report Financial Results for First Quarter 2025 on April 23, 2025

Pfizer Halts Obesity Pill Development Amid Safety Concerns

Zacks

24 days ago

Pfizer Halts Obesity Pill Development Amid Safety Concerns

Smaller obesity drugmakers jump after Pfizer scraps weight-loss pill

TipRanks

24 days ago

Smaller obesity drugmakers jump after Pfizer scraps weight-loss pill

Down 71%, Should You Buy the Dip on Viking Therapeutics Stock?

Motley Fool

24 days ago

Down 71%, Should You Buy the Dip on Viking Therapeutics Stock?

NVO, LLY, GPCR & VKTX Stocks Gain Following PFE's Obesity Study Setback

Zacks

24 days ago

NVO, LLY, GPCR & VKTX Stocks Gain Following PFE's Obesity Study Setback

Why Viking Therapeutics, Inc. (VKTX) Skyrocketed On Monday?

Insider Monkey

25 days ago

Why Viking Therapeutics, Inc. (VKTX) Skyrocketed On Monday?

Why Eli Lilly, Novo Nordisk, and Viking Therapeutics Stocks All Popped Today

Motley Fool

25 days ago

Why Eli Lilly, Novo Nordisk, and Viking Therapeutics Stocks All Popped Today

3 Magnificent Stocks That Could Double or More by 2030

Motley Fool

a month ago

3 Magnificent Stocks That Could Double or More by 2030

Will Viking Therapeutics Be a Top Healthcare Stock in 10 Years?

Motley Fool

a month ago

Will Viking Therapeutics Be a Top Healthcare Stock in 10 Years?

MT Newswires

a month ago

Goldman Sachs Initiates Viking Therapeutics With Neutral Rating, $30 Price Target

The Smartest Biotech Stocks to Buy With $50

Motley Fool

a month ago

The Smartest Biotech Stocks to Buy With $50

Viking Therapeutics, Down 40%, Just Reached a New Milestone. Is the Stock a Buy Now?

Motley Fool

a month ago

Viking Therapeutics, Down 40%, Just Reached a New Milestone. Is the Stock a Buy Now?

Viking Therapeutics, Inc. (VKTX) Stock Slides as Market Rises: Facts to Know Before You Trade

Zacks

a month ago

Viking Therapeutics, Inc. (VKTX) Stock Slides as Market Rises: Facts to Know Before You Trade

Viking Therapeutics (NasdaqCM:VKTX) Seals Manufacturing Deal as Stock Declines 11% Over The Past Month

Simply Wall St.

a month ago

Viking Therapeutics (NasdaqCM:VKTX) Seals Manufacturing Deal as Stock Declines 11% Over The Past Month

Brokers Suggest Investing in Viking Therapeutics (VKTX): Read This Before Placing a Bet

Zacks

a month ago

Brokers Suggest Investing in Viking Therapeutics (VKTX): Read This Before Placing a Bet

VKTX Finishes Enrolment in Mid-Stage Study on Oral Weight-Loss Drug

Zacks

a month ago

VKTX Finishes Enrolment in Mid-Stage Study on Oral Weight-Loss Drug

Viking Therapeutics Skids Despite 'Rapid' Enrollment In Obesity Pill Study

Investor's Business Daily

a month ago

Viking Therapeutics Skids Despite 'Rapid' Enrollment In Obesity Pill Study

Viking Therapeutics Announces Completion of Enrollment in Phase 2 VENTURE-Oral Dosing Trial of VK2735 Tablet Formulation in Patients with Obesity

PR Newswire

a month ago

Viking Therapeutics Announces Completion of Enrollment in Phase 2 VENTURE-Oral Dosing Trial of VK2735 Tablet Formulation in Patients with Obesity

Viking Therapeutics, Inc. (VKTX) Rises But Trails Market: What Investors Should Know

Zacks

2 months ago

Viking Therapeutics, Inc. (VKTX) Rises But Trails Market: What Investors Should Know

Better Stock to Buy Right Now: Viking Therapeutics vs. Eli Lilly

Motley Fool

2 months ago

Better Stock to Buy Right Now: Viking Therapeutics vs. Eli Lilly

1 Biotech Stock Down 52% That Could Soar by 233%, According to Wall Street

Motley Fool

2 months ago

1 Biotech Stock Down 52% That Could Soar by 233%, According to Wall Street

Down 65% From Its 52-Week High, Is Viking Therapeutics Stock a Bargain Buy?

Motley Fool

2 months ago

Down 65% From Its 52-Week High, Is Viking Therapeutics Stock a Bargain Buy?

Viking Therapeutics (NasdaqCM:VKTX) Soars 10% With CordenPharma Manufacturing Agreement

Simply Wall St.

2 months ago

Viking Therapeutics (NasdaqCM:VKTX) Soars 10% With CordenPharma Manufacturing Agreement

Viking Therapeutics, Inc. (VKTX) Ascends While Market Falls: Some Facts to Note

Zacks

2 months ago

Viking Therapeutics, Inc. (VKTX) Ascends While Market Falls: Some Facts to Note

Sage Therapeutics (SAGE) Up 7.4% Since Last Earnings Report: Can It Continue?

Zacks

2 months ago

Sage Therapeutics (SAGE) Up 7.4% Since Last Earnings Report: Can It Continue?

How to Play VKTX Stock Amid Manufacturing Deal With CordenPharma

Zacks

2 months ago

How to Play VKTX Stock Amid Manufacturing Deal With CordenPharma

Why Viking Therapeutics Inc. (VKTX) Is Skyrocketing Today?

Insider Monkey

2 months ago

Why Viking Therapeutics Inc. (VKTX) Is Skyrocketing Today?

Why Viking Therapeutics and Roche Holdings Popped Today, but Novo Nordisk Stock Dropped

Motley Fool

2 months ago

Why Viking Therapeutics and Roche Holdings Popped Today, but Novo Nordisk Stock Dropped

B. Riley sees two key positives in Viking manufacturing agreement

TipRanks

2 months ago

B. Riley sees two key positives in Viking manufacturing agreement

VKTX Inks Manufacturing Deal With CordenPharma for Obesity Drug Supply

Zacks

2 months ago

VKTX Inks Manufacturing Deal With CordenPharma for Obesity Drug Supply

Viking strikes $150m deal to secure supply of obesity drug

Pharmaceutical Technology

2 months ago

Viking strikes $150m deal to secure supply of obesity drug

Viking Therapeutics Just Inked A $150 Million Manufacturing Deal. Here's Why Shares Crumbled.

Investor's Business Daily

2 months ago

Viking Therapeutics Just Inked A $150 Million Manufacturing Deal. Here's Why Shares Crumbled.

Stellantis, Tesla, Viking Therapeutics: Market Minute

Yahoo Finance Video

2 months ago

Stellantis, Tesla, Viking Therapeutics: Market Minute

Viking Therapeutics closer to bringing its Ozempic competitor to market

Quartz

2 months ago

Viking Therapeutics closer to bringing its Ozempic competitor to market

MT Newswires

2 months ago

Update: Viking Therapeutics Shares Fall After Manufacturing Deal With CordenPharma

H.C. Wainwright says Novo results support Viking obesity potential

TipRanks

2 months ago

H.C. Wainwright says Novo results support Viking obesity potential

Wall Street Bulls Look Optimistic About Viking Therapeutics (VKTX): Should You Buy?

Zacks

2 months ago

Wall Street Bulls Look Optimistic About Viking Therapeutics (VKTX): Should You Buy?

MT Newswires

2 months ago

Viking Therapeutics Signs Manufacturing Deal With CordenPharma for Obesity Program

Viking Therapeutics Signs Broad Manufacturing Agreement With CordenPharma to Support Commercialization of VK2735

PR Newswire

2 months ago

Viking Therapeutics Signs Broad Manufacturing Agreement With CordenPharma to Support Commercialization of VK2735

This Weight Loss Stock Could Skyrocket by 462%, According to Wall Street

Motley Fool

2 months ago

This Weight Loss Stock Could Skyrocket by 462%, According to Wall Street

Viking Therapeutics, Inc. (VKTX) Beats Stock Market Upswing: What Investors Need to Know

Zacks

2 months ago

Viking Therapeutics, Inc. (VKTX) Beats Stock Market Upswing: What Investors Need to Know

Why Viking Therapeutics, Inc. (VKTX) Soared on Tuesday

Insider Monkey

2 months ago

Why Viking Therapeutics, Inc. (VKTX) Soared on Tuesday

Viking Therapeutics to Participate at Upcoming Investor Conferences

PR Newswire

2 months ago

Viking Therapeutics to Participate at Upcoming Investor Conferences

Viking Therapeutics (NasdaqCM:VKTX) Reports US$35M Q4 Loss As Stock Falls 12%

Simply Wall St.

2 months ago

Viking Therapeutics (NasdaqCM:VKTX) Reports US$35M Q4 Loss As Stock Falls 12%

AbbVie Enters The Obesity Arena. Why It's Paying Up To $2.23 Billion.

Investor's Business Daily

2 months ago

AbbVie Enters The Obesity Arena. Why It's Paying Up To $2.23 Billion.

Viking Therapeutics, Inc. (VKTX) Ascends But Remains Behind Market: Some Facts to Note

Zacks

2 months ago

Viking Therapeutics, Inc. (VKTX) Ascends But Remains Behind Market: Some Facts to Note

Is Viking Therapeutics, Inc. (VKTX) the Worst Performing Mid Cap Stock to Buy According to Analysts?

Insider Monkey

2 months ago

Is Viking Therapeutics, Inc. (VKTX) the Worst Performing Mid Cap Stock to Buy According to Analysts?

1 Biotech Stock to Buy in 2025, and 1 to Avoid

Motley Fool

2 months ago

1 Biotech Stock to Buy in 2025, and 1 to Avoid

3 Beaten-Down Biotech Stocks to Buy Before They Soar. Wall Street Is Predicting Jumps of 68% to 250%.

Motley Fool

2 months ago

3 Beaten-Down Biotech Stocks to Buy Before They Soar. Wall Street Is Predicting Jumps of 68% to 250%.

Viking Therapeutics, Inc. (VKTX): A Bull Case Theory

Insider Monkey

2 months ago

Viking Therapeutics, Inc. (VKTX): A Bull Case Theory

Is Viking Therapeutics a Buy Right Now?

Motley Fool

2 months ago

Is Viking Therapeutics a Buy Right Now?

Perrigo Gears Up to Report Q4 Earnings: Here's What to Expect

Zacks

2 months ago

Perrigo Gears Up to Report Q4 Earnings: Here's What to Expect

Viking Therapeutics (VKTX): Among the Oversold Biotech Stocks to Buy Now

Insider Monkey

3 months ago

Viking Therapeutics (VKTX): Among the Oversold Biotech Stocks to Buy Now

Should You Buy VKTX Stock Amid Renewed M&A Speculations?

Zacks

3 months ago

Should You Buy VKTX Stock Amid Renewed M&A Speculations?

Wall Street Thinks This Weight Loss Drug Stock Could More Than 3X Over the Next 12 Months -- and It's Not Eli Lilly or Novo Nordisk

Motley Fool

3 months ago

Wall Street Thinks This Weight Loss Drug Stock Could More Than 3X Over the Next 12 Months -- and It's Not Eli Lilly or Novo Nordisk

Why Viking Therapeutics Inc. (VKTX) Surged On Friday?

Insider Monkey

3 months ago

Why Viking Therapeutics Inc. (VKTX) Surged On Friday?

Why Viking Therapeutics, Inc. (VKTX) Went Up On Wednesday?

Insider Monkey

3 months ago

Why Viking Therapeutics, Inc. (VKTX) Went Up On Wednesday?

MT Newswires

3 months ago

Scotiabank Initiates Viking Therapeutics at Sector Outperform

Why Viking Therapeutics Inc. (VKTX) Went Down on Monday

Insider Monkey

3 months ago

Why Viking Therapeutics Inc. (VKTX) Went Down on Monday

Why Hims & Hers Health Stock Crushed Novo Nordisk and Viking Therapeutics Today

Motley Fool

3 months ago

Why Hims & Hers Health Stock Crushed Novo Nordisk and Viking Therapeutics Today

2 Stocks to Buy With Less Than $40

Motley Fool

3 months ago

2 Stocks to Buy With Less Than $40

3 No-Brainer Healthcare Stocks to Buy With $200 Right Now

Motley Fool

3 months ago

3 No-Brainer Healthcare Stocks to Buy With $200 Right Now

The M&A boom of 2025 is just getting started — and here are 5 potential targets

MarketWatch

3 months ago

The M&A boom of 2025 is just getting started — and here are 5 potential targets

Viking Therapeutics price target lowered to $96 from $109 at B. Riley

TipRanks

3 months ago

Viking Therapeutics price target lowered to $96 from $109 at B. Riley

2 Stocks That Could Soar Again in 2025

Motley Fool

3 months ago

2 Stocks That Could Soar Again in 2025

Down 65%, Is Viking Therapeutics Stock a Buy on the Dip?

Motley Fool

3 months ago

Down 65%, Is Viking Therapeutics Stock a Buy on the Dip?

MT Newswires

3 months ago

B. Riley Adjusts Price Target on Viking Therapeutics to $96 From $109, Keeps Buy Rating

Share on Social Networks: